Citigroup »

Crescent Biopharma shares owned by Citigroup

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $371k 20k 18.37

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Crescent Biopharma

FMR
BVF
Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Balyasny Asset Management
Vestal Point Capital
Opaleye Management
Tang Capital Management
Vanguard Capital Management
Vanguard Group
Logos Global Management
Deep Track Capital
Boxer Capital Management
Rtw Investments

View all funds holding Crescent Biopharma